Erlotinib-Conjugated Iron Oxide Nanoparticles as a Smart Cancer-Targeted Theranostic Probe for MRI

We designed and synthesized novel theranostic nanoparticles that showed the considerable potential for clinical use in targeted therapy, and non-invasive real-time monitoring of tumors by MRI. Our nanoparticles were ultra-small with superparamagnetic iron oxide cores, conjugated to erlotinib (FeDC-E...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Ahmed Atef Ahmed, Hsu, Fei-Ting, Hsieh, Chia-Ling, Shiau, Chia-Yang, Chiang, Chiao-Hsi, Wei, Zung-Hang, Chen, Cheng-Yu, Huang, Hsu-Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105135/
https://www.ncbi.nlm.nih.gov/pubmed/27833124
http://dx.doi.org/10.1038/srep36650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105135/
https://www.ncbi.nlm.nih.gov/pubmed/27833124
http://dx.doi.org/10.1038/srep36650

Ejemplares similares